Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
J Neurointerv Surg ; 11(1): 57-61, 2019 Jan.
Article in English | MEDLINE | ID: mdl-29674482

ABSTRACT

PURPOSE: To evaluate the clinical outcome of patients with venous malformation (VM) involving the eyelid treated with bleomycin sclerotherapy. METHODS: A retrospective review was performed of 18 consecutive patients with VM involving the eyelid who underwent bleomycin sclerotherapy. Patients' clinical presentation, details of sclerotherapy, and post-sclerotherapy resolution of the lesion as well as any procedure-related complications were evaluated. RESULTS: Twelve women and six men of mean age 34.3±20.4 years underwent sclerotherapy with bleomycin. Chief complaints were cosmetic disfigurations with or without hemifacial deformity (n=2), pain in engorgement area (n=2), pain and swelling from venous thrombosis (n=2), swelling or engorgement obstructing their eyesight (n=2), or eyelid dysfunction (n=1). The lesions were only in the eyelid in three patients; otherwise they were extended out of the eyelid either superiorly (n=3), laterally (n=8), inferiorly (n=8), and/or posteriorly to the orbit (n=8) to various extents. Conjunctival involvement was present in 13 patients. 14 patients had received prior treatments including surgery, laser therapy, or non-bleomycin sclerotherapy. With an average three sessions of bleomycin sclerotherapy (average total dose 34.5 mg), more than 80% shrinkage was observed in seven patients (38.9%), 50-80% shrinkage in eight patients (44.4%), and 30-50% shrinkage in two patients (11.1%). One patient had recurrence, which was successfully treated again with bleomycin. No procedure-related complications were noted. CONCLUSIONS: The use of bleomycin appears to be a simple, safe, and effective treatment for venous malformations involving the eyelid, avoiding more elaborate and challenging surgical or laser interventions, and is even effective in full thickness lesions.


Subject(s)
Bleomycin/therapeutic use , Eyelids/diagnostic imaging , Laser Therapy , Sclerosing Solutions/therapeutic use , Sclerotherapy/methods , Vascular Malformations/therapy , Adult , Antibiotics, Antineoplastic/therapeutic use , Child , Eyelids/blood supply , Female , Humans , Male , Middle Aged , Retrospective Studies , Treatment Outcome , Veins/abnormalities , Veins/diagnostic imaging
2.
Cornea ; 38(3): 304-310, 2019 Mar.
Article in English | MEDLINE | ID: mdl-30531497

ABSTRACT

PURPOSE: To investigate the efficacy of topical carbomer-based lipid-containing artificial tears (CLAT) and hyaluronate (HU) in patients with dry eye disease (DED) based on serum 25-hydroxyvitamin D (25HD) levels and cholecalciferol (vitamin D) supplementation. METHODS: A total of 116 patients with DED from June 2015 to June 2016 were included. The participants were divided into the vitamin D deficiency (VDD) group and the non-VDD group according to their serum 25HD levels. The patients determined the ways of cholecalciferol supplementation. Ocular Surface Disease Index (OSDI) score, visual analog pain scale score, lid hyperemia, tear breakup time (TBUT), corneal fluorescein staining score, and Schirmer test were compared between baseline and 2 weeks posttreatment after topical applications and between before and after cholecalciferol supplementation. RESULTS: The OSDI and visual analog pain scale scores of both VDD and non-VDD groups decreased after application of topical CLAT and HU compared with baseline values (P < 0.05 for all, paired t test). TBUT, corneal fluorescein staining score, and lid hyperemia in the VDD group remained unaffected by topical CLAT and HU, whereas those in the non-VDD group were improved (3.2 ± 1.7 vs. 4.1 ± 2.2, 0.5 ± 0.7 vs. 0.4 ± 0.6, and 2.2 ± 0.8 vs. 1.9 ± 0.7 in the non-VDD group, P = 0.001, 0.030, and 0.012, respectively). OSDI score, TBUT, and lid margin hyperemia were improved in the intramuscular group after cholecalciferol supplementation compared with pretreatment (33.2 ± 23.2 vs. 28.5 ± 21.9, 3.5 ± 1.9 vs. 6.0 ± 2.5, and 2.2 ± 0.7 vs. 1.2 ± 0.8, P < 0.05, Wilcoxon rank test). CONCLUSIONS: The effect of topical CLAT and HU was dependent on serum 25HD levels. Cholecalciferol supplementation enhanced the efficacy of topical treatment and may be a useful adjuvant therapy for patients with DED refractory to topical lubricants.


Subject(s)
Dietary Supplements , Dry Eye Syndromes/drug therapy , Hyaluronic Acid/therapeutic use , Lubricant Eye Drops/therapeutic use , Viscosupplements/therapeutic use , Vitamin D/therapeutic use , Vitamins/therapeutic use , Adult , Aged , Aged, 80 and over , Dry Eye Syndromes/physiopathology , Eye Pain/pathology , Eyelids/blood supply , Female , Humans , Hyperemia , Male , Middle Aged , Tears/metabolism , Vitamin D Deficiency , Young Adult
3.
Ophthalmic Plast Reconstr Surg ; 34(2): 123-129, 2018.
Article in English | MEDLINE | ID: mdl-28221297

ABSTRACT

OBJECTIVE: This study investigates the hypoperfusion effects of epinephrine in local anesthesia in eyelid surgery. A novel form of extended-wavelength diffuse reflectance spectroscopy was evaluated. METHODS: Blood perfusion in porcine eyelid flaps was measured using laser Doppler velocimetry and laser speckle contrast imaging, whereas the tissue response was measured using diffuse reflectance spectroscopy with a broad spectrum (450-1550 nm). Epinephrine was either injected cumulatively, 0.1 (1:10,000,000), 1.0 (1:1,000,000), 10 (1:100 000), and 100 µg/ml (1:10 000), to determine the dose-response relation, or given as a single dose (10 µg/ml). Control experiments were performed with saline or lidocaine. RESULTS: Increasing concentrations of epinephrine resulted in a gradual decrease in tissue perfusion, measured by laser Doppler velocimetry and laser speckle contrast imaging, approaching a minimum after the injection of 10 µg/ml. Similar tissue response was observed with diffuse reflectance spectroscopy. The time from the injection of epinephrine (10 µg/ml) to the stabilization of hypoperfusion was 75 seconds. After administration of 10 µg/ml epinephrine, about 20% of the blood perfusion remained, supporting the use of epinephrine in eyelid flaps with a narrow pedicle. CONCLUSIONS: 10 µg/ml epinephrine appears to be adequate for vasoconstriction before oculoplastic surgery. Incisions need only be delayed for about 1 minute. Extended-wavelength diffuse reflectance spectroscopy appears to be a promising technique for monitoring the tissue response following changes in blood perfusion in plastic surgery reconstructions. However, more rigorous validation of the technique is required before it can be implemented in clinical practice.


Subject(s)
Anesthesia, Local/methods , Anesthetics, Local/pharmacology , Epinephrine/pharmacology , Eyelids , Vasoconstrictor Agents/pharmacology , Anesthetics, Local/administration & dosage , Animals , Disease Models, Animal , Dose-Response Relationship, Drug , Epinephrine/administration & dosage , Eyelids/blood supply , Eyelids/drug effects , Laser-Doppler Flowmetry , Regional Blood Flow/drug effects , Spectrum Analysis , Surgical Flaps/blood supply , Swine , Vasoconstriction/drug effects
4.
Australas J Dermatol ; 55(4): 289-91, 2014 Nov.
Article in English | MEDLINE | ID: mdl-24417640

ABSTRACT

The popularity of intense pulsed light (IPL) therapy continues to increase due to its relative safety, high skin coverage rate and ability to treat both vascular and pigmented lesions. An often-overlooked risk is the potential for IPL-induced ocular damage. The damage sustained can cause significant, persistent morbidity and can occur even with very limited IPL exposure to the eye.


Subject(s)
Capillaries/abnormalities , Intense Pulsed Light Therapy/adverse effects , Iritis/etiology , Vascular Malformations/therapy , Adult , Eyelids/blood supply , Female , Humans , Iritis/drug therapy , Telangiectasis/therapy
5.
Minerva Chir ; 68(6 Suppl 1): 1-9, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24172759

ABSTRACT

Orbital region may be divided into four sectors: medial canthus, lateral canthus, lower lid and upper lid. A vertical section of a lid shows 5 layers: skin, subcutaneous tissue with orbicularis muscle, fibrous layer (tarsus-aponeurosis), plain fibers muscle layer (Muller's), conjunctiva. The first two layers form the "anterior lamella" and the other ones the "posterior lamella", divided by the grey line. In this review Authors describe with all details the orbital region and the eyelid layers, considering the most important concepts for surgery. Finally they resume basics of local anesthesia in ophthalmoplastic surgery.


Subject(s)
Eyelids/surgery , Ophthalmologic Surgical Procedures/methods , Anesthesia, Local/methods , Anesthetics, Local/administration & dosage , Eyelids/anatomy & histology , Eyelids/blood supply , Eyelids/innervation , Humans , Lacrimal Apparatus/anatomy & histology , Lacrimal Apparatus/surgery , Nerve Block/methods , Plastic Surgery Procedures/methods
6.
Ophthalmic Plast Reconstr Surg ; 24(6): 488-90, 2008.
Article in English | MEDLINE | ID: mdl-19033852

ABSTRACT

Venous malformations of the skin and subcutaneous tissue are compressible, blue-purple tumors that are present at birth. According to the location and symptoms caused, venous malformations can be treated with surgery, sclerotherapy, or a combination of both. Laser therapy can also be used, especially when surgery is contraindicated. We report the case of a 24-year-old man who presented with a venous malformation on the upper and lower left eyelids, which provoked a mechanical ptosis. Treatment with sequential pulsed-dye neodymium yttrium aluminum garnet (PDL-Nd:YAG) laser was performed. After 2 treatments, a marked reduction of volume and blanching of the venous malformation was observed, with satisfactory cosmetic results. The sequential PDL-Nd:YAG laser seems to be an effective and safe therapy for the treatment of cutaneous venous malformations. It penetrates deeper than pulsed-dye laser alone, and because it allows the use of lower fluencies than Nd:YAG laser alone, it reduces the risk of adverse effects.


Subject(s)
Eyelids/blood supply , Lasers, Solid-State/therapeutic use , Low-Level Light Therapy/methods , Vascular Malformations/radiotherapy , Veins/abnormalities , Blood Flow Velocity/radiation effects , Eyelids/diagnostic imaging , Eyelids/pathology , Follow-Up Studies , Humans , Male , Ultrasonography, Doppler , Vascular Malformations/diagnostic imaging , Vascular Malformations/physiopathology , Veins/diagnostic imaging , Young Adult
7.
Perspect Vasc Surg Endovasc Ther ; 20(4): 348-55, 2008 Dec.
Article in English | MEDLINE | ID: mdl-18987009

ABSTRACT

Ambulatory phlebectomy is a minor, office-based surgical procedure designed to remove varicose veins. It is a perfect complement to endovenous thermal ablation of the saphenous vein. With this combination, patients can expect all varicose veins to vanish following a 1-hour procedure that employs only local anesthesia in the comfort of a physician's office. Advantages of office-based surgery are ease of scheduling for doctors and patients, less paperwork, elimination of travel time, and cost containment for the health care system. Furthermore, a procedure that is performed by the same staff daily is more streamlined and safe.


Subject(s)
Ambulatory Surgical Procedures , Saphenous Vein/surgery , Varicose Veins/surgery , Vascular Surgical Procedures , Ambulatory Surgical Procedures/adverse effects , Ambulatory Surgical Procedures/economics , Ambulatory Surgical Procedures/instrumentation , Ambulatory Surgical Procedures/methods , Anesthesia, Local , Cost Control , Equipment Design , Eyelids/blood supply , Foot/blood supply , Hand/blood supply , Health Care Costs , Humans , Patient Satisfaction , Patient Selection , Postoperative Care , Sclerotherapy , Stockings, Compression , Time Factors , Vascular Surgical Procedures/adverse effects , Vascular Surgical Procedures/economics , Vascular Surgical Procedures/instrumentation , Vascular Surgical Procedures/methods
8.
Jpn J Ophthalmol ; 50(3): 205-10, 2006.
Article in English | MEDLINE | ID: mdl-16767373

ABSTRACT

PURPOSE: To investigate whether disodium cromoglycate (DSCG) inhibits capsaicin-induced eosinophil infiltration of the conjunctiva independent of mast cells. METHODS: We administered 5 microl of capsaicin solution (10(-5) M) into the conjunctival sacs of mast cell-deficient W/W(v) mice (12 animals) and wild-type mice (12 animals). As controls, the eyes of 12 wild-type and 12 W/W(v) mice were treated with phosphate-buffered saline. Following treatment, the eyelids and eyeballs were removed en bloc at 3, 9, or 24 h, and were histologically examined. The number of infiltrated eosinophils and the expression of vascular cell adhesion molecule-l (VCAM-1) in the conjunctiva were quantified by the staining method of Hansel and immunohistochemical analysis. We also investigated whether treatment by depletion of neuropeptides or by DSCG administration could suppress the capsaicin-induced eosinophil infiltration of the conjunctiva. RESULTS: In both W/W(v) and wild-type mice, eosinophil infiltration of conjunctival tissues was observed 3 h after capsaicin administration. In both strains of mice, the number of infiltrated eosinophils increased over time, with VCAM-1 expression on vascular endothelial cells peaking at 9 h after treatment, and decreasing gradually within 24 h after treatment. In both the neuropeptide-depleted and the DSCG-treated groups, eosinophil infiltration and VCAM-1 expression were suppressed in comparison with the nontreated group. CONCLUSION: DSCG can directly inhibit neuropeptide-induced eosinophil infiltration of the conjunctiva independent of mast cells.


Subject(s)
Anti-Asthmatic Agents/therapeutic use , Conjunctival Diseases/drug therapy , Cromolyn Sodium/therapeutic use , Eosinophilia/drug therapy , Mast Cells/pathology , Animals , Capsaicin/toxicity , Conjunctiva/blood supply , Conjunctiva/drug effects , Conjunctiva/metabolism , Conjunctival Diseases/chemically induced , Conjunctival Diseases/pathology , Disease Models, Animal , Endothelium, Vascular/metabolism , Eosinophilia/chemically induced , Eosinophilia/pathology , Eyelids/blood supply , Eyelids/drug effects , Eyelids/metabolism , Immunohistochemistry , Male , Mice , Vascular Cell Adhesion Molecule-1/biosynthesis
9.
J Cataract Refract Surg ; 29(4): 842-4, 2003 Apr.
Article in English | MEDLINE | ID: mdl-12686260

ABSTRACT

A 52-year-old man had loss of vision and black discoloration of the lids of the right eye after a retrobulbar injection of 3 mL lidocaine hydrochloride 2% (Xylocaine). Examination of the right eye revealed no light perception with extensive necrosis of the lids. Anterior segment examination revealed conjunctival pallor, corneal edema, and necrosis of the sclera. This is a previously unreported complication of retrobulbar anesthesia comprising ophthalmic artery occlusion with scleral melt, ocular ischemia, and eyelid necrosis.


Subject(s)
Anesthesia, Local/adverse effects , Eyelid Diseases/etiology , Eyelids/pathology , Sclera/pathology , Scleral Diseases/etiology , Anesthetics, Local/administration & dosage , Arterial Occlusive Diseases/etiology , Epinephrine/administration & dosage , Eyelids/blood supply , Humans , Injections , Ischemia/etiology , Lidocaine/administration & dosage , Male , Middle Aged , Necrosis , Ophthalmic Artery/pathology , Orbit , Sclera/blood supply
SELECTION OF CITATIONS
SEARCH DETAIL